Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chi-Yi Chen

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
Archives of Osteoporosis|July 23, 2018
Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: a nationwide population-based cohort studyHerng-Sheng Lee, Chi-Yi Chen, Wan-Ting Huang, et al.
Japanese Journal of Clinical Oncology|February 4, 2015
Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patientsYu-Min Feng, Chin-Wen Feng, Chin-Li Lu, et al.
Oncotarget|April 16, 2016
Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2Min-Che Tung, Po-Lin Lin, Ya-Wen Cheng, et al.
Frontiers in Oncology|November 8, 2021
Efficacy of Cyproheptadine Monotherapy in Hepatocellular Carcinoma With Bone Metastasis: A Case ReportYu-Min Feng, Tsung-Hsien Chen, Dara Berman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2010
cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancerHeng-Hsiung Wu, Jeng-Yuan Wu, Ya-Wen Cheng, et al.
Hepato-Gastroenterology|May 17, 2003
High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis CPin-Nan Cheng, Chung-Min Jen, Kung-Chia Young, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 4, 2009
Low dose erythropoietin-beta improves anemia and maintains ribavirin dose in chronic hepatitis C patients receiving combination therapy with ribavirin plus pegylated interferon Alfa-2bKuo-Chih Tseng, Li-Hsuan Chen, Chi-Yi Chen, et al.
Trials|July 8, 2018
Comparison of cold and hot snaring polypectomy for small colorectal polyps: study protocol for a randomized controlled trialYen-Nien Chen, Li-Chun Chang, Chi-Yang Chang, et al.
American Journal of Cancer Research|December 9, 2020
Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective studyChien-Hung Chen, Chi-Yi Chen, Jing-Houng Wang, et al.
Journal of Gastroenterology and Hepatology|January 19, 2018
Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 studyJia-Horng Kao, Min-Lung Yu, Chi-Yi Chen, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
Archives of Osteoporosis|July 23, 2018
Risk of fractures at different anatomic sites in patients with irritable bowel syndrome: a nationwide population-based cohort studyHerng-Sheng Lee, Chi-Yi Chen, Wan-Ting Huang, et al.
Japanese Journal of Clinical Oncology|February 4, 2015
Cyproheptadine significantly improves the overall and progression-free survival of sorafenib-treated advanced HCC patientsYu-Min Feng, Chin-Wen Feng, Chin-Li Lu, et al.
Oncotarget|April 16, 2016
Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2Min-Che Tung, Po-Lin Lin, Ya-Wen Cheng, et al.
Frontiers in Oncology|November 8, 2021
Efficacy of Cyproheptadine Monotherapy in Hepatocellular Carcinoma With Bone Metastasis: A Case ReportYu-Min Feng, Tsung-Hsien Chen, Dara Berman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2010
cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor/phosphatidylinositol 3-kinase/AKT pathway confers resistance to cisplatin in human papillomavirus 16/18-infected lung cancerHeng-Hsiung Wu, Jeng-Yuan Wu, Ya-Wen Cheng, et al.
Hepato-Gastroenterology|May 17, 2003
High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis CPin-Nan Cheng, Chung-Min Jen, Kung-Chia Young, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 4, 2009
Low dose erythropoietin-beta improves anemia and maintains ribavirin dose in chronic hepatitis C patients receiving combination therapy with ribavirin plus pegylated interferon Alfa-2bKuo-Chih Tseng, Li-Hsuan Chen, Chi-Yi Chen, et al.
Trials|July 8, 2018
Comparison of cold and hot snaring polypectomy for small colorectal polyps: study protocol for a randomized controlled trialYen-Nien Chen, Li-Chun Chang, Chi-Yang Chang, et al.
American Journal of Cancer Research|December 9, 2020
Comparison of incidence of hepatocellular carcinoma between chronic hepatitis B patients with cirrhosis treated with entecavir or tenofovir in Taiwan - a retrospective studyChien-Hung Chen, Chi-Yi Chen, Jing-Houng Wang, et al.
Journal of Gastroenterology and Hepatology|January 19, 2018
Twelve-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin for non-cirrhotic HCV genotype 1 patients: A phase 2 studyJia-Horng Kao, Min-Lung Yu, Chi-Yi Chen, et al.
Pageof 14